Cancer Care Ontario | Action Cancer Ontario

zanubrutinib - For the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) who have received at least one prior therapy; and for the treatment of adult patients with previously untreated CLL.

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

zanubrutinib

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Drug

zanubrutinib

Other Name(s): Brukinsa®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Dec 1969

Guidelines and Advice

Stem Cell Transplantation in the Treatment of Acute Lymphoblastic Leukemia: Recommendations

Status: Archived
ID: SCT 6

Dec 1969

Regimen

SEVA

Cancer Type:

Lung,

Non-Small Cell

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

sevabertinib (Unfunded)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Screening Activity Report: Frequently Asked Questions

The following information answers many of the questions primary care physicians commonly ask about the Screening Activity Report and the included...

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Soins de la bouche pendant les traitements contre le cancer

zolbetuximab

Screening for Lung Cancer

Systemic Treatment – Quality-Based Procedure (ST-QBP)

Systemic Treatments for Unresectable and Metastatic Cutaneous Melanoma

Surgical, Radiation, and Systemic Treatments of Patients with Thymic Epithelial Tumours

ZANU

ZANU

zanubrutinib

Stem Cell Transplantation in the Treatment of Acute Lymphoblastic Leukemia: Recommendations

SEVA

Screening Activity Report: Frequently Asked Questions

Pages